99mTc MIP 1404

DRUG2 trials

Sponsors

Molecular Insight Pharmaceuticals, Inc.

Conditions

Prostate Cancer

Phase 1

A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers

CompletedNCT01261754

Molecular Insight Pharmaceuticals, Inc.Prostate Cancer

Start: 2010-12-31Updated: 2015-11-25

A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer

CompletedNCT01615406

Molecular Insight Pharmaceuticals, Inc.Prostate Cancer

Start: 2012-04-30Updated: 2015-11-25